Corbus Pharmaceuticals Holdings (CRBP) Notes Payables (2013 - 2024)
Corbus Pharmaceuticals Holdings' (CRBP) quarterly Notes Payables came in at $77000.0 in Q2 2024, up 50.52% year-on-year from $51157.0 in Q3 2023, and up 607.59% quarter-over-quarter from $10882.0 in Q1 2024.
Corbus Pharmaceuticals Holdings (CRBP) Notes Payables (2013 - 2024) Analysis & Trends
Corbus Pharmaceuticals Holdings' Notes Payables history runs 12 years deep, the most recent figure standing at $77000.0 for Q2 2024.
- On a quarterly basis, Notes Payables rose 50.52% year-over-year to $77000.0 in Q2 2024; TTM through Jun 2024 was $77000.0, a 50.52% increase from a year earlier, with the FY2023 full-year figure at $301000.0, up 716.43% from the prior year.
- Notes Payables grew to $77000.0 in Q2 2024 per CRBP's latest filing, from $10882.0 in the prior quarter.
- Across five years, Notes Payables topped out at $803000.0 in Q1 2021 and bottomed at $10882.0 in Q1 2024.
- The 5-year median for Notes Payables is $133710.0 (2021), against an average of $263105.4.
- Across the five-year window, Notes Payables soared 716.43% in 2023 and sank 94.65% in 2024, its largest moves.
- Year by year, Notes Payables stood at $797000.0 in 2020, then sank by 83.22% to $133710.0 in 2021, then plunged by 72.43% to $36868.0 in 2022, then surged by 716.43% to $301000.0 in 2023, then sank by 74.42% to $77000.0 in 2024.
- Per Business Quant, the three latest CRBP Notes Payables figures stand at $77000.0 (Q2 2024), $10882.0 (Q1 2024), and $301000.0 (Q4 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 77,000.00 |
| Mar 31, 2024 | 10,882.00 |
| Dec 31, 2023 | 301,000.00 |
| Jun 30, 2023 | 51,157.00 |
| Mar 31, 2023 | 203,258.00 |
| Dec 31, 2022 | 36,868.00 |
| Jun 30, 2022 | 133,710.00 |
| Mar 31, 2022 | 133,710.00 |
| Dec 31, 2021 | 133,710.00 |
| Sep 30, 2021 | 126,857.00 |
| Jun 30, 2021 | 102,693.00 |
| Mar 31, 2021 | 803,000.00 |
| Dec 31, 2020 | 797,000.00 |
| Sep 30, 2020 | 757,000.00 |
| Jun 30, 2020 | 108,936.00 |
| Mar 31, 2020 | 432,905.00 |
| Dec 31, 2019 | 752,659.00 |
| Jun 30, 2019 | 99,333.00 |
| Mar 31, 2019 | 247,384.00 |
| Dec 31, 2018 | 394,305.00 |